Multiple Sclerosis Journal: Experimental, Translational and Clinical

Impact Factor: 2.3

Coeditors-in-Chief: Ho J. Kim, Jeff Cohen, Mar Tintore

Discipline: Clinical Medicine

Description:

Journal HighlightsNow discoverable in PubMedCentral.The open access companion journal to Multiple Sclerosis Journal.Articles received more than 130,000 full-text downloads in 2022.Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. For more information on the journal please visit the aims and scope tab.As an open access publication, all articles are freely available online immediately upon publication. All articles are rigorously peer-reviewed, and brought to publication as rapidly as possible.The journal is also a member of the Committee on Publication Ethics (COPE).Submission informationSubmit your manuscript today at https://mc.manuscriptcentral.com/msj-etc.Please see the submission guidelines tab for more information on how to format your manuscript.Open access informationPublication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.The APC for this journal is 3000 USD.Members of the American Committee for Treatment and Research in Multiple Sclerosis, the European Committee for Treatment and Research in Multiple Sclerosis, the Latin American Committee for Treatment and Research in Multiple Sclerosis, the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis or Rehabilitation in Multiple Sclerosis will receive a 75% discount on the APC.The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here.